Infection
Infectious agents are an important cause of cancer worldwide, especially in low- and middle-income countries.
While infections (bacteria, viruses, parasites) are responsible for an estimated 12% of new cancer cases annually worldwide, they cause more than one-quarter of all cancers in many low-income countries in Africa and Asia (Map 5.1).
The five most important cancer-causing infectious agents are Helicobacter pylori (850,000 cases globally), human papillomavirus (HPV) (730,000), hepatitis B virus (HBV) (380,000), hepatitis C virus (HCV) (170,000), and Epstein-Barr virus (EBV) (200,000) (Figure 5.1).
Leading cancer-causing infections worldwide (%), by sex, 2020
MALES
FEMALES
The contribution of each infectious agent to cancer burden varies substantially across different regions (Figure 5.2).
Proportion (%) of cancers attributable to infectious agents, by agent and UN region, 2020
Footnote
Sub-Saharan Africa includes sub-regions of Western, Middle, Eastern and South Africa.
Helicobacter pylori causes 90% of stomach cancers, the majority of which occur in Eastern Asia. HPV infection is a necessary cause of cervical cancer, the leading cause of cancer death among women in many low-income countries, and is also responsible for a substantial proportion of anal, vulvar, vaginal, penile, and head and neck cancers (Figure 5.3).
The major infection-related cancers are stomach, cervix, and liver.
Most common infection-related cancers worldwide, 2020
Worldwide, HBV and HCV infections account for 55% and 21% of liver cancer deaths, respectively, with HBV tending to be the predominant cause of liver cancer in less developed countries and HCV in more developed settings. EBV causes lymphomas, nasopharyngeal carcinoma, and 7% of stomach cancer. Other cancer-causing infections include Kaposi sarcoma-associated herpesvirus (HHV-8; 42,000 cases, mainly in sub-Saharan Africa), human T-cell lymphotropic virus, Merkel cell virus, liver flukes, and Schistosoma haematobium. Human immunodeficiency virus (HIV) also indirectly causes infection-related cancers through immunosuppression and is estimated, for example, to be responsible for 20% of cervical cancer and 80% of Kaposi sarcoma in sub-Saharan Africa.
“I stand by the HPV vaccine as a critical advancement in preventive healthcare. Its widespread adoption is essential to protect future generations from the devastating effects of HPV-related cancers.”
Effective prevention strategies exist for infection-related cancers, including HPV and HBV vaccines, screening for cervical and anal HPV-related precancer, and drugs to treat HBV, HCV, Helicobacter pylori, and HIV infections. EBV vaccines and EBV-targeted immunotherapies are in development.
The World Health Organization (WHO) has launched global mobilization efforts for the elimination of liver cancer (HBV and HCV), and cervical cancer (HPV), as public health concerns.